CLINICAL_TRIALS
trial_result
· 2022-01-06
Clinical Trial Update: The Effect of Ixazomib on the Latent HIV Reservoir [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating ixazomib for reducing the latent HIV reservoir; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Human Immunodeficiency Virus (HIV) | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-01-06